Science and Development Network
News, views and information about science, technology and the developing world
Source: Newsweek
30 June 2009 | EN
Destined to die: the offspring of the genetically modified mosquitoes die as larvae
Flickr/bgv23
Denying Aedes aegypti mosquitoes the chance to be parents could potentially curb dengue fever — but environmentalists are wary of the risks involved.
Dengue fever is a debilitating, sometimes fatal disease that affects more than 100 million people in 100 countries. It has no cure so scientists are turning to genetically modified (GM) mosquitoes.
A strategy devised at Oxford University, United Kingdom, involves inserting a gene into male A.aegypti that causes their offspring to die as larvae.
The plan is to release a swarm of GM males into the wild and await the A.aegypti population's decline. The idea has only recently gained widespread support, most notably from the Bill and Melinda Gates Foundation which has invested US$38 million in the research.
But critics disapprove of such interference with the world's ecosystems, describing it as "arrogant". Others have pointed out that some mosquito-borne diseases, such as malaria, do not need this kind of approach because they can already be prevented and treated.
Supporters, however, say the technology could save millions of lives in the developing world.
"If you are sitting with your pregnant wife in a hospital in Tanzania or Malawi, then you are not going to be so worried about the escape of a few mosquitoes," says Arthur Caplan at the University of Pennsylvania, United States.
The WHO is developing strict protocols for testing GM mosquitoes. And researchers say they are committed to taking "an extraordinarily cautious approach".
Add your comment
All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.
You need to be signed in to post a comment or to email a consenting comment author. Please sign in or sign up.